Stock listing
NASDAQ:CEGE Cell Genesys Inc Stock
Follow Cell Genesys Inc into a list and get an email when it puts out news.
Last close · NASDAQ:CEGE
$0.327 USD
Close on Oct 14, 2009 · No longer trades
- Lowest – highest close
- $0.102 – $52.000 USDSince Jan 4, 1999 · lowest Oct 24, 2008 · highest Mar 3, 2000
Delisted NASDAQ:CEGE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:CEGE
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Cell Genesys Inc on 6ix
- Decks
- 1 deck · latest Aug 7, 2009
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (August 2009) | Merger or acquisition | 19 slides | Aug 7, 2009 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Stephen A. Sherwin Other companies: Biogen Inc. (Director · Since at least Mar 20, 2010); Neurocrine Biosciences, Inc. (Director · Since at least Jun 30, 2006); Epiphany Technology Acquisition Corp (Director · Sep 16, 2022 – Sep 16, 2022 · Past); BioPlus Acquisition Corp (Director · Dec 2, 2021 – Dec 2, 2021 · Past); Aduro Biotech Inc (Director · Jun 25, 2015 – May 5, 2020 · Past); Vical Incorporated (Director · May 23, 2013 – May 21, 2015 · Past); Verastem, Inc. (Director · Mar 5, 2013 – Jun 12, 2015 · Past); ANI Pharmaceuticals, Inc. (Director · Oct 14, 2009 – Mar 30, 2012 · Past); Rigel Pharmaceuticals, Inc. (Director · May 31, 2006 – May 11, 2016 · Past) | Chairman and CEO, Director · Feb 7, 2006 – Oct 14, 2009 · Past |
Log in to ask 6ix AI your own questions about Cell Genesys Inc.